Current advance of nanotechnology in diagnosis and treatment for malignant tumors.
Wang B, Hu S, Teng Y, Chen J, Wang H, Xu Y, Wang K, Xu J, Cheng Y, Gao X. · 2024
Read Current advance of nanotechnology in diagnosis and treatment for malignant tumors. by Wang B, Hu S, Teng Y, Chen J, Wang H, Xu Y, Wang K, Xu J, Cheng Y, Gao X. (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc11323968.txt.
Introduction
Wang and colleagues review nanotechnology for finding and treating malignant tumours in this 2024 paper. Cancer is still a major threat to human health. Nanomedicine engineers particles at the scale of billionths of a metre for medical use. Such particles can serve as contrast agents that sharpen scans, enabling high sensitivity and high-resolution tumour detection.
Nanoprobes and nanobiosensors open further routes to label and detect tumours, the authors say. For therapy, engineered carriers ferry drugs or gene fragments into tumour tissue. They reach it by passive leaking through tumour vessels or by active homing to tumour markers. That targeting boosts effect while sparing healthy tissue. Particles also sensitise tumours to radiation and power heat-based therapy. The review summarises designs and results across these uses.
Catalog record
| CREATOR | Wang B, Hu S, Teng Y, Chen J, Wang H, Xu Y, Wang K, Xu J, Cheng Y, Gao X. |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 737 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |